Detecting and tracking Alzheimer's disease using electrochemical sensors

Electrochemical sensors for the detection and tracking of Alzheimer’s disease

NIH-funded research University of Delaware · NIH-11018379

This study is working on creating new sensors that can easily and accurately check for signs of Alzheimer's disease in your blood, helping to catch it early and manage it better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Delaware NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project IDNIH-11018379 on NIH RePORTER

What this research studies

This research focuses on developing advanced electrochemical sensors to detect and monitor Alzheimer's disease (AD) biomarkers in blood or plasma. The goal is to create organic electrochemical transistors (OECTs) that can provide sensitive and specific measurements of Amyloid-β, a key biomarker for AD. By improving the detection methods, the research aims to facilitate early diagnosis and continuous monitoring of the disease, which is crucial for timely therapeutic interventions. Patients may benefit from more accessible and cost-effective testing options that can help manage their condition more effectively.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease or those experiencing early symptoms of dementia.

Not a fit: Patients with advanced Alzheimer's disease or those who do not exhibit any symptoms of cognitive decline may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and better management of Alzheimer's disease, improving patients' quality of life.

How similar studies have performed: Other research has shown promise in using biosensors for detecting biomarkers in various conditions, suggesting that this approach could be effective for Alzheimer's disease as well.

Where this research is happening

Newark, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.